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ABSTRACT 
 
Insulin Dynamic Measures and Weight Change 
 
By 
 
Noreen Kloc 
B.S. Computer Information Technology, Purdue University 
 
December 7, 2015 
 
INTRODUCTION:   Weight gain and obesity are risk factors for insulin resistance that can lead to type 2 
diabetes and cardiovascular disease; however, there is a complicated interplay between insulin 
sensitivity (SI), fasting insulin, acute insulin response (AIR), and disposition index (DI) and the 
relationship of these dynamic measures with weight change is not well understood. 
AIM: The aim of this study was to investigate the relationships between insulin dynamic measures, SI, 
fasting insulin, AIR, and DI, with weight change during a 5-years follow-up period in the multi-ethnic 
cohort of the Insulin Resistance Atherosclerosis Study (IRAS). 
METHODS: Data on 879 men and women of Hispanic, non-Hispanic White, and African-American 
race/ethnicity aged 40-69 years were obtained at baseline (1992-1994) and at 5 year follow-up. Crude 
associations between the insulin dynamic measures and weight change were evaluated using Kruskal-
Wallis test and the relationships between log-transformed insulin-related variables were examined using 
Spearman rank-order analysis. Multivariate regression models evaluated associations of interest 
adjusted for age, sex, ethnicity, and diabetes status in a time-dependent manner using mixed models.  
RESULTS:  Insulin sensitivity SI inversely coevolves with weight, i.e. greater weight is predicted by lower 
SI at any time point. To answer the question whether SI is the cause or a consequence of weight change, 
we examined the associations with the baseline values and a change in SI. In this model, both the 
baseline SI and change in SI were inversely correlated with weight gain. A similar approach showed that 
baseline values and change in fasting insulin were directly associated with weight gain. Weight change 
over time was associated with AIR, i.e. increases in AIR and greater AIR at baseline predicted weight 
gain. We did not find strong relationships between DI and weight change. 
DISCUSSION: These results suggest that insulin sensitivity and insulin secretion can modulate weight in 
a non-diabetic population. 
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Insulin Dynamic Measures and Weight Change 
 
I. Introduction  
Weight gain and obesity are risk factors for insulin resistance that can lead to type 2 diabetes 
and cardiovascular disease (CVD) (1). Physiologically, insulin is a hormone produced in the 
pancreas and moves into the blood helping glucose to be incorporated into cells. Muscle, fat 
and liver cells absorb glucose from the bloodstream which then lowers blood glucose levels. 
Insulin stimulates the liver and muscle tissue to incorporate the excess glucose. Insulin 
resistance is a syndrome in which insulin is produced but not used effectively causing the 
glucose to build up in the blood leading to impaired glucose status or type 2 diabetes (2). Other 
clinical diseases associated with insulin resistance syndrome are CVD, hypertension, polycystic 
ovary syndrome, nonalcoholic liver disease, sleep apnea, several types of cancer (3) and may be 
a risk for coronary heart disease and stroke (4). 
There is a complicated interplay between weight gain, insulin sensitivity, and insulin secretion. 
Weight gain leads to a drop in insulin sensitivity (increase in insulin resistance). In non-diabetic 
individuals, change in insulin sensitivity is often compensated by an increase in insulin secretion 
and fasting insulin. Such compensation can produce a metabolic environment that promotes 
further weight gain.  Insulin is known to promote weight gain in diabetic patients who take 
insulin as a part of their regimen. Thus, not only does weight gain promote insulin resistance 
but a compensatory increase in insulin can stimulate further weight increase, creating a vicious 
cycle. The aim of this study was to investigate how the insulin dynamic factors, insulin 
sensitivity (SI), fasting insulin, acute insulin response (AIR), and disposition index (DI) influence 
weight change during a 5-year period in a cohort of 879 triethnic participants. 
II. Review of the Literature 
Research into insulin dynamics and weight change has been conducted for several decades; 
however the relationship is complicated. A higher SI value expresses insulin sensitivity as a 
measure of insulin-stimulated glucose disposal. This is an inverse measure of insulin resistance. 
Another index of insulin resistance is higher fasting insulin.  A higher AIR implies greater insulin 
secretion in response to glucose, which might be greater when insulin action is diminished. A 
product of SI and AIR, DI offsets the influence of insulin resistance on AIR and is accepted as an 
index of pancreatic function (5).  
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The beneficial effect of weight loss on glucose tolerance has been documented in many 
research studies (6-9). However, the relationship of glucose regulation to changes in weight is 
not clear with studies documenting varying results. Early studies suggested insulin resistance 
may cause weight gain due to reduced thermic effects (10), increased appetite (11), or a genetic 
artifact for increased fat storage (12); but later studies have suggested insulin resistance might 
increase fat oxidation (13), or serve as a homeostatic mechanism protecting against weight gain 
(14, 15).  A large population study showed that people who have been diagnosed with diabetes 
tend to not gain weight or lose excess weight (16).  These studies provided weak evidence since 
biological tests and relevant confounders were not included.  
The results of studies using clinical measures differ in their results due to different measures of 
insulin dynamics and weight, varying lengths of follow-up, and controlling for different 
confounders. Animal and human studies suggest that insulin dynamics including insulin 
sensitivity and insulin secretion are associated with weight change but the direction of that 
change (negative or positive) is inconsistent with different studies (17, 18). Age, sex, 
race/ethnicity, diabetic status, BMI, energy expenditure, smoking status, alcohol consumption 
and length of follow-up varied in study population parameters and the length of follow-up.   
The studies examining the relationship of poor insulin dynamics and wait gain found that higher 
levels of fasting insulin at baseline predict visceral fat (19) or weight change (20, 21) during the 
follow-up. These studies did not include age or initial weight in the analysis, only non-diabetic 
adults were included, one study controlled for lifestyle variables (i.e. physical activity and diet 
fat intake), and the study follow-up period differed between 3 and 10 years.  
Other studies documented a positive association of insulin dynamic measures to changes in 
weight with average plasma glucose predicting more weight gain (22-24) or higher insulin 
resistance at baseline predicted weight loss or no weight change during follow-up (15, 24-27). 
The studies that controlled for demographic variables included age, sex and race/ethnicity, four 
controlled for medication (22, 24, 26, 27) and some controlled for lifestyle behavior (15, 22, 27).  
The finding of these studies was that poor glucose was associated with lower weight gain but 
did not vary with age, initial weight, sex, and race/ethnicity while two studies found that insulin 
resistance and less weight gain were greater in participants not using insulin (24, 26).  
Studies that documented complex relationships between glucose regulation and changes in 
weight suggest that age, sex, race/ethnicity, baseline weight, and specific measures of weight 
can affect the results. A five year longitudinal study controlling for age and BMI found results 
differed by race/ethnicity (28). In Chinese men, weight gain was predicted by insulin resistance 
which differed in Asian Indian and Creole adults where weight gain was predicted by better 
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insulin sensitivity. In addition, only body weight was associated with insulin resistance and no 
relationship was found in waist to hip ratio (28).   
In reviewing the findings of the existing studies, the aim of this current study was to utilize a 
large study population of diverse race/ethnicity and demographic parameters, include relevant 
biological measures and control for relevant confounders including BMI, sex, age, and diabetes 
status.   
III. Methods and Procedures  
The Insulin Resistance Atherosclerosis Study (IRAS) was designed to assess the relation of 
insulin and insulin resistance to cardiovascular disease and its risk factors. Details of the IRAS 
study design have been previously published (29). The study protocols were approved by the 
institutional review boards of each clinical center located in Oakland, California; Los Angeles, 
California; San Antonio, Texas; and the San Luis Valley, Colorado (29).  All participants provided 
written informed consent.  
Sample Selection 
The study recruited 1624 male and female participants aged 40 – 69 years from four geographic 
areas representing three ethnic groups (Hispanic, non-Hispanic white, and African-American) in 
1992-1994.  A follow-up period of approximately 5 years occurred between 1997 and 1998. 
Participants with existing diabetes status, missing weight at baseline or missing weight at 
follow-up were eliminated from the study population (n=730).  Diabetic patients exhibit shifting 
insulin dynamics and insulin secretion in response to weight which differs between diabetics 
and non-diabetics and these patients often intentionally try to lose weight (1, 18). An additional 
four participants were eliminated due to a mismatch in weight and waist circumference and 
one participant with duplicate ID was removed. Eleven more participants with missing relevant 
data were eliminated with a final study population of 879.   
Variable Measurement 
During the first visit at each time point, a 75-g oral glucose tolerance test (OGTT) was used to 
assess glucose tolerance status based on the World Health Organization (WHO) criteria (30) and 
to determine fasting insulin concentration (26).  The WHO diabetes status criteria using the 
OGTT :  normal < 140 mg/dl, impaired 140 – 199 mg/dl, and diabetic ≥ 200 mg/dl (30). During 
the second visit at east time point, insulin sensitivity and first-phase insulin secretion were 
measured by FSIGTT with minimal model analysis (31).  Insulin resistance, expressed as the 
Insulin Sensitivity Index (SI) was calculated using mathematical modeling methods (MINMOD, 
version 3.0, Los Angeles, California, courtesy of Richard Bergman, PhD) (32).  To assess 
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sensitivity of β–cell function, insulin secretion was measured by the AIR variable as the mean of 
plasma concentration from 2- and 4-minute time points after glucose administration (26). 
Disposition Index (DI) is an alternate insulin secretion variable based on the hyperbolic relation 
of insulin secretion to SI and expresses the ability of the pancreatic β–cell to compensate for 
changes in SI by increasing insulin secretion (33, 34). DI was calculated as the product of SI and 
AIR. BMI was calculated as weight in kilograms divided by height in meters squared. 
Race/Ethnicity and other demographic data were assessed by self-report. Anthropometric 
measurements were obtained by trained personnel.   
Statistical Analysis 
All statistical analysis was performed using SAS statistical software (version 9.3, SAS Institute, 
Cary, NC). In multivariate correlations and regression models, log-transformed values of fasting 
insulin, AIR, SI and DI were used to minimize the influence of extreme observations.  Some 
individuals had an SI value of zero so the natural logarithm of SI was added to the contant 1 was 
used for transformation.  DI was calculated as the sum of log-transformed SI + 1 and log-
transformed AIR.  A weight change status variable grouped the difference in weight between 
baseline and follow-up into Increased Weight (≥5%), No Weight Change (<>5%) and Decreased 
Weight (≤5%).  
The crude associations of weight change status and covariates were examined using chi-square 
test for the ordinal and categorical variables, and Kurskal-Wallis for all continuous variables 
including the main exposure variables SI, Fasting Insulin, AIR and DI. Crude associations of the 
log-transformed insulin dynamic measures at baseline and at follow-up were evaluated using 
Spearman correlation coefficient as a nonparametric measure of association based on the rank 
order of the SI, Fasting Insulin, AIR and DI values.  Similarly, Spearman correlation coefficient 
was used to examine the associations between the log-transformed insulin dynamic measures 
at baseline and with the measures at follow-up.  
Mixed effects models were created to examine the adjusted associations of weight and the 
insulin dynamic measure during the baseline and follow-up periods.  The random effects 
included random intercepts and random slopes at the individual level and random intercepts at 
the clinic level. The fixed effects adjusted for baseline age, sex, race/ethnicity, baseline BMI and 
time-dependent diabetes status. SI, fasting Insulin, AIR and DI were included separately in each 
model and were scaled to have unit variance. This analysis explained how weight coevolves 
with the insulin measures of interest.  
In addition, this study analyzed a cross-sectional and prospective relationship between weight 
change and the insulin dynamic measures.  In these models, time was presented as number of 
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months between the baseline and follow-up visits, whereas age at baseline was used as an 
adjustment variable. The insulin variables were presented as baseline value and change 
between follow-up and baseline. Interaction term between time and the baseline insulin 
measure presented a prospective relationship. We report three parameters for each insulin-
related measure adjusted by  age, sex, ethnicity, baseline BMI and time-dependent diabetes 
status: beta-coefficient for baseline variable presents cross-sectional association with weight at 
baseline, beta-coefficient for the interaction term between baseline values and time presents a 
prospective association between baseline and weight at follow-up, and beta-coefficient for 
change variable shows associations between change in the variable and weight during the 
follow-up period.  The beta-coefficient and standard error values were scaled by the standard 
deviations of the corresponding predictors. These models answered the question of whether 
the dynamic measure of interest can be causal in relation to weight change.  
IV. Results 
Descriptive characteristics of the study population by weight change status (≥5% Increased 
Weight, <> 5% No Weight Change, and ≤5% Decreased Weight) are shown in Table 1.  At the 
follow-up visit, 31% of the participants had increased weight, 58% had little weight change, and 
12% had decreased weight.  There was a significant difference in the proportions of females 
across weight groups: 61% females/39% males increased weight, 53% females/48% males had 
little weight change, and 66% females/34% males decreased weight (p<0.008). The results 
suggest BMI at baseline was significantly associated with weight change: participants with 
greater BMI were more likely to change weight in either direction whereas participants with 
lower BMI tended to have little weight change (p<0.02). Race/ethnicity was not associated with 
weight change. Participants with normal glucose tolerance (NGT) at baseline showed a greater 
tendency to increased weight (p=0.06).The overall test for the association between glucose 
tolerance/diabetes status and weight change showed no association, participants who 
developed diabetes also had a tendency to increase weight. Insulin sensitivity at baseline was 
similar among all three weight-change groups. During the follow-up, SI decreases on average at 
follow-up with the greatest change among those who gained weight (-1.1 mean difference) as 
compared to participants with stable weight (-0.8 mean difference) and a no change among 
those with weight decrease p<0.001).  As expected, relationship with Fasting insulin mirror 
those with SI:  participants with Increased Weight experienced the greatest increase in fasting 
insulin (+6.4 mean change) as compared to participants with No Weight Change( +2.5 mean 
change), whereas participants with Decreased Weight showed no meaningful changes in fasting 
insulin (p<0.001).  Baseline acute insulin response showed a tendency toward inverse 
association with weight change with the greatest values among those who gained weight and 
lowest among those who lost weight (p=0.2). In all three weight change groups, AIR increased 
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over time (Increased Weight + 23.4 mean difference, No Weight Change +16.7 mean difference, 
Decreased Weight +2.7 mean difference) and these changes amplified the differences at the 
follow-up  (p<0.001).  Disposition Index at baseline showed a clear tendency of inverse 
association with weight change with the greatest values among those who gained weight   and 
lowest among those who lost weight (p<0.01). However, the changes in DI were different 
among the three groups: participants with increased weight experienced the greatest drop in DI 
followed by those with relatively stable weight, whereas those who lost weight showed 
increase in DI at follow-up. The opposite tendencies in DI change between the weight loss and 
weight gain groups narrowed the gap in DI at follow-up as compared to baseline (p value for 
the difference between the groups at follow-up = 0.1).  
Table 1. Characteristics of study population by weight change status 
N=879 Increased Weight 
(≥5%) n=268 
No Weight Change         
(<> 5%) n=510 
Decreased Weight        
(≤5%) n=101 
P 
Age (years) 52.3±8.2 55.7±8.3 55.6±8.9 <0.001 
Male (%) 104 (39) 242 (47.5) 34 (33.7) 0.008 
Female (%) 164 (61) 268 (52.6) 67 (66.3) 0.008 
Ethnicity  
         White 
 
106 (39.6) 
 
205 (40.2) 
 
41 (40.6) 
0.4 
         African American 79 (29.5) 125 (24.5) 31 (30.7)  
         Hispanic 83 (31) 180 (35.3) 29 (28.7)  
BMI (kg/m2) at baseline 28.6±5.8 27.9±5.3 29.5 (5.3) 0.02 
Glucose Tolerance (Diabetes 
Status)  at baseline 
        Normal  
 
 
189 (72.5) 
 
 
342 (67.1) 
 
 
58 (57.4) 
 
0.06 
        Impaired  79 (29.5) 168 (33) 43 (42.6)  
Glucose Tolerance (Diabetes 
Status) at follow-up 
        Normal  
 
 
140 (52.2) 
 
 
301 (59) 
 
 
55 (54.5) 
 
0.4 
        Impaired  80 (29.9) 128 (25.1) 31 (30.7)  
        Diabetic  48 (17.9) 81 (15.9) 15 (14.9)  
Insulin Sensitivity (SI)          
(SI, x10-4minutes-1/µUml)          
at baseline 
 
                          
2.2±1.9 
 
                         
2.2±1.9 
 
                              
1.9±1.6 
 
                   
0.2 
Insulin Sensitivity (SI)          
(SI, x10-4minutes-1/µUml)            
at follow-up 
 
                             
1.1±1.4 
 
                             
1.4±1.4 
 
                            
1.9±1.4 
 
   
<0.001 
Fasting Insulin (uU/mL)          
at baseline 
 
15.0±10.9 
 
15.8±17.4 
 
16.2±9.5 
 
0.3 
Fasting Insulin (uU/mL)          
at follow-up 
 
21.4±13.7 
 
18.3±13.2 
 
16.1±9.1 
 
<0.001 
Acute Insulin Response (AIR)  
(µU/ml X minutes)                
at baseline 
 
                     
68.8±51.6 
 
                  
65.0±61.2 
 
                   
59.4±44.4 
 
          
0.2 
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Acute Insulin Response (AIR) 
(µU/ml X minutes)                
at follow-up 
 
                            
92.2±72.3 
 
                        
81.7±79.0 
 
                 
62.1±44.8 
 
 
<0.001 
Disposition Index (SI X AIR)    
at baseline 
 
131.2±125.4 
 
111.1±112.9 
 
93.7±92.0 
 
<0.001 
Disposition Index (SI X AIR)    
at follow-up 
 
91.0±103.3 
 
96.9±110.9 
 
97.3±82.6 
 
0.1  
Data are n (%) and means ± SD.  Categorical variables and age were assessed using Chi-square test. Continuous 
variables were assessed using Kruskal-Wallis test. AIR is the mean of 2,4 minute insulin injection.  
 
To assess the association between the insulin dynamic measures at baseline, Spearman 
correlation coefficient test was used to rank-order pairs of SI, fasting insulin, AIR and DI as 
shown in Table 2.  As expected, there is a strong inverse association between fasting insulin and 
SI (r = -0.66, p<0.001). Fasting insulin was positively correlated with AIR (r = 0.33, p<0.001) and 
negatively correlated with DI (r = -0.10, p<0.005).  AIR was correlated with SI (r  =  -0.30, 
p<0.001).  Strongly associated AIR and DI is determined by the mathematical relationship 
between AIR and DI.  DI was also correlated with SI (r = 0.34, p<0.001). 
Table 2.  Correlation between insulin dynamic measures at baseline 
N=879 Log Insulin 
Sensitivity 
Log Fasting 
Insulin 
Log Acute Insulin 
Response 
Log 
Disposition 
Index 
Log Insulin Sensitivity 
Spearman Corr. 
Sig. (2-tailed) 
N 
 
. 
. 
. 
 
-0.66 
<.0001 
817 
 
-0.30 
<.0001 
818 
 
0.34 
<.0001 
818 
Log Fasting Insulin 
Spearman Corr. 
Sig. (2-tailed) 
N 
 
-0.66 
<.0001 
817 
 
. 
. 
. 
 
0.33 
<.0001 
840 
 
-0.10 
0.005 
817 
Log Acute Insulin 
Response 
Spearman Corr. 
Sig. (2-tailed) 
N 
 
 
-0.30 
<.0001 
818 
 
 
0.33 
<.0001 
840 
 
 
. 
. 
. 
 
 
0.76 
<.0001 
818 
     
Spearman correlation coefficient rho [r], Prob >[r]. Log-transformed SI, fasting insulin, AIR and DI. 
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Next, the association of insulin dynamic measures between baseline and follow-up periods are 
shown in Table 3 to assess the correlation of the insulin variables between visits.   As expected 
all predictors at baseline have high correlation with the follow-up period. Similar to Table 2, the 
correlations remain significant with the exception of the correlation between baseline DI and 
fasting insulin at follow-up which changes to not significant (r = -0.06, p = 0.11). Fasting insulin 
and SI are inversely correlated which was also found in previous studies examining the IRAS 
cohort (26, 35). 
Table 3. Correlation of insulin dynamic measures between baseline and at follow-up 
N=879 Log Insulin 
Sensitivity 
Follow-up 
Log Fasting 
Insulin 
Follow-up 
Log Acute Insulin 
Response 
Follow-up 
Log Disposition 
Index 
Follow-up 
Log Insulin Sensitivity 
baseline 
Spearman Corr. 
Sig. (2-tailed) 
N 
 
 
0.64 
<.0001 
737 
 
 
-0.56 
<.0001 
813 
 
 
-0.11 
0.002 
756 
 
 
0.22 
<.0001 
736 
Log Fasting Insulin 
Baseline 
Spearman Corr. 
Sig. (2-tailed) 
N 
 
 
-0.51 
<.0001 
780 
 
 
0.60 
<.0001 
872 
 
 
0.14 
<.0001 
802 
 
 
-0.12 
0.0006 
779 
Log Acute Insulin Response 
Baseline 
Spearman Corr. 
Sig. (2-tailed) 
N 
 
 
 
-0.20 
<.0001 
759 
 
 
 
0.31 
<.0001 
836 
 
 
 
0.69 
<.0001 
778 
 
 
 
0.53 
<.0001 
758 
Log Disposition Index 
Baseline 
Spearman Corr. 
Sig. (2-tailed) 
N 
 
 
0.22 
<.0001 
737 
 
 
-0.06 
0.11 
813 
 
 
0.61 
<.0001 
756 
 
 
0.69 
<.0001 
736 
Spearman correlation coefficient rho [r], Prob >[r]. Log-transformed SI, fasting insulin, AIR and DI. 
 
The next analysis used a mixed-effects model approach to examine SI, fasting insulin, AIR, DI 
that predicted weight.  Table 4 shows time-dependent relationships between each insulin 
dynamic measure and weight during the follow-up period adjusting for baseline age, sex, 
race/ethnicity, central adiposity (baseline BMI) and  glucose tolerance (diabetes status).  The 
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strongest associations with weight in time were found for the variables related with insulin 
resistance. SI shows an inverse association with weight in time: β = -0.91, 95% CI=(-1.27,-0.56), 
and fasting insulin positively correlates with weight β = 0.96, 95% CI=(0.64, 1.27). Response of 
the pancreases to glucose challenge showed weaker relationships with weight in time:  AIR 
positively correlates with weight β = 0.38, 95% CI=(0.05, 0.73) and there is a weak tendency for 
inverse relationship between DI and weight.   
Table 4. Weight and insulin dynamics during the follow-up period adjusted for age, sex, race/ethnicity, 
baseline BMI, and diabetes status and clinic included as a cluster variable 
 Beta-coefficient (SE) 95% CI P-value 
Log SI -0.91 (0.18) 
 
-1.27, -0.56 <.0001 
Log Fasting insulin 0.96 (0.16) 
 
0.64, 1.27 <.0001 
Log AIR  0.38 (0.17) 
 
0.05, 0.73 0.02 
Log DI -0.22 (0.18) -0.56, -0.13 0.22 
Beta-coefficient and standard error values are scaled to one standard deviation. 
In Table 5, the relationships between each insulin dynamic predictor and weight is presented in 
three ways – cross-sectional association at baseline, association with change in the insulin 
measures, and a prospective association between baseline insulin measures and weight at the 
end of follow-up. This approach did not reveal any meaningful cross-sectional associations 
between insulin measures and weight at baseline. The strongest relationships were found 
between changes in the examined insulin measures and weight. Baseline values predicted 
weight change in a similar direction (except DI), but these associations were weaker.    This 
approach showed that the change in SI was inversely associated with weight: β = -2.43, 95% 
CI=(-2.99, -1.87).  Also, greater insulin sensitivity at baseline predicted loss of weight when time 
elapsed for a long duration (t>0.123, β = -0.17, 95% CI=(-0.27,-0.08).  Increase in fasting insulin 
implied weight gain: β = 2.10, 95% CI= (1.61, 2.60). Greater baseline fasting insulin also 
predicted increase of weight:  β = 0.13, 95% CI=(0.04, 0.22).  Similarly, increase in AIR had a 
positive association with weight: β = 1.11, 95% CI=(0.67, 1.55).  Baseline AIR predicted weight 
gain: β = 0.11, 95% CI=(0.03, 0.19).  DI did not show strong relationships with weight in this 
model. 
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Table 5. Associations of weight with baseline and change of insulin-related variables adjusted for age, 
sex, race/ethnicity, baseline BMI, and diabetes status and clinic included as a cluster variable 
 Beta-coefficient scaled to SD 
Cross-sectional  Assoc.         Association with Change             Prospective Association 
Log SI 
 β (SE) 
95% CI 
P 
 
0.30 (0.25) 
-0.19, 0.80 
0.23 
 
-2.43 (0.28) 
-2.99, - 1.87 
<.0001 
 
- 0.17 (0.05) 
-0.27, -0.08 
0.0002 
Log Fasting 
insulin 
β (SE) 
95% CI 
P 
 
 
 
0.001 (0.24) 
-0.46,  0.47 
1.00 
  
 
2.10 (0.25) 
1.61, 2.60 
<.0001 
 
 
0.13 (0.04) 
0.04, 0.22 
0.003 
Log AIR 
 β (SE) 
95% CI 
P 
 
-0.02 (0.22) 
-0.46,  0.41 
0.91 
. 
1.11 (0.22) 
0.67, 1.55 
<.0001 
 
0.11 (0.04) 
0.03,  0.19 
0.008 
Log DI 
β (SE) 
95% CI 
P 
 
0.10 (0.23) 
-0.35, 0.55 
0.66 
 
-0.48 (0.29) 
-1.05, - 0.08 
0.09 
 
0.06 (0.05) 
-0.03,  0.15 
0.18 
Beta-coefficient and standard error values are scaled to one standard deviation. 
 
V. Discussion and Conclusion 
The aim of this study was to investigate the insulin dynamic factors: insulin sensitivity (SI), 
fasting insulin, acute insulin response (AIR), and disposition index (DI) associated with weight 
change in a cohort of multiethnic participants. The hyperbolic law of glucose tolerance states 
that DI should remain constant as long as changes in the insulin action are compensated for by 
the changes in insulin secretion to maintain glucose homeostasis (1, 36). Although it is possible 
that one of the insulin measures would play a dominant role, the pathways that determine 
observed levels of these metabolic predictors are interdependent as a function of biologic 
feedback systems (26, 37).  We hypothesized that insulin resistance measures will increase but 
the insulin secretion measures will decrease with weight gain as the body compensates for 
energy imbalance.   
Our study showed that all insulin dynamic measures are interrelated. Fasting insulin and AIR 
increase to compensate for lower insulin sensitivity, whereas DI shows pancreatic beta-cell 
function with the offset for insulin resistance (Tables 2 & 3). The crude associations show that 
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greater insulin secretion (AIR and DI) at baseline predict a risk of weight gain. However, weight 
gain leads to a decline in beta-cell function and therefore a decrease in DI (Table 1), whereas 
weight loss improves beta-cell function leading to an increase in DI (Table1). As insulin 
resistance is known to be associated with weight gain, time-dependent associations of weight 
with insulin measures show an inverse association with SI and positive association with fasting 
insulin. Weight increase was also associated with insulin secretion probably as a compensation 
for increased insulin resistance (Table 4). When insulin measures were presented as baseline 
values, changes and the interaction between baseline and time, the cross-sectional associations 
were not important. Their change was mainly associated with weight dynamics and the baseline 
values showed associations with weight at follow-up in the expected direction.  These results 
imply that insulin measures are mostly a consequence of weight change (strong correlation 
with change) and to a lesser degree a cause of weight changes (interaction between baseline 
and time).   
A strength of this study design as identified in the review article by Chiu et al. was that few 
recent studies have examined weight  as an outcome variable and also include laboratory tests 
to evaluate the insulin dynamic variables (17).  Additionally, the study population was a large 
sample with even representation of men and women from a diverse race/ethnic background 
which were followed for a 5 year period. Few current studies have a large sample size or ethnic 
diversity. The statistical approach provided analysis of the insulin parameter of interest at 
baseline, and the change in value over time related to predicting weight change. 
Although the range of laboratory tests and anthropometric measures were comprehensive in 
this study, selection of participants for a clinical study may reflect a different variability than the 
general population.   
Future directions for research could investigate the diabetic status of individuals and 
relationship with weight change. Participants with impaired glucose status may have different 
associations than what we found in the current study. A better understanding of insulin 
dynamics may lead to earlier diagnosis of an imbalanced metabolic state and provide additional 
prevention programs to reduce morbidity associated with any negative impact of weight 
change.  
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